Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2026-02-23 @ 7:48 AM
Study NCT ID:
NCT01808118
Status:
COMPLETED
Last Update Posted:
2018-05-30
First Post:
2013-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Axial Spondyloarthritis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Spondylitis | View |
| None | Spondylarthropathy | View |
| None | Ankylosing Spondyloarthritis | View |
| None | Spondyloarthritis | View |
| None | Spinal Diseases | View |
| None | Musculoskeletal Diseases | View |
| None | Arthritis | View |
| None | Joint Diseases | View |
| None | Adalimumab | View |
| None | Antirheumatic Agents | View |
| None | Anti-Inflammatory Agents | View |